At SNMMI ‘16, Siemens Healthineers Debuts MI Software, Mobile PET/CT System
Jun 09, 2016
SNMMI 2016: Booth 531
· syngo.via for Molecular Imaging preprocessing/reading/reporting tool now available for SPECT as well as PET
· New mobile configuration of Biograph Horizon1 enables broader delivery of premium PET/CT performance at low total cost of ownership
At the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 11-15 at the San Diego Convention Center, Siemens Healthineers offers molecular imaging solutions without compromise, including a new release of its established syngo®.via for Molecular Imaging preprocessing, reading, and reporting software for positron emission tomography/computed tomography (PET) and – for the first time – single-photon emission computed tomography (SPECT). The company also introduces a new mobile configuration of its Biograph Horizon™ PET/CT system, offering premium performance at a low total cost of ownership.
syngo.via for Molecular Imaging
The new version of the syngo.via for Molecular Imaging software solution from Siemens Healthineers enables preprocessing, reading, and reporting for both PET and SPECT, enabling physicians to use the intuitive user interface to allow for synergies across departments using syngo.via.
The new iteration of syngo.via for Molecular Imaging offers four new features. For SPECT, organ processing for nuclear medicine helps physicians visualize and quantify the physiological characteristics of organs such as the lungs, kidneys and stomach. For PET, the Molecular Tumor Volume (MTV) and Total Lesion Glycolysis (TLG) features together enable physicians to measure the standardized metabolic activity of the entire tumor mass, potentially improving the preoperative identification of high-risk patients and the prognostic value in predicting overall survival; and hybrid gating 4D visualization of PET and CT supports therapy planning and delivery.
And syngo.via MI Workplace – the company’s cost-effective, scalable configuration of syngo.via for Molecular Imaging – is designed to bolster the performance of PET and SPECT scanners. In addition to image processing, syngo.via MI Workplace may increase diagnostic confidence by quantifying disease parameters in a wide range of clinical areas. Available with the Biograph Horizon PET/CT system and with all Symbia™ SPECT and SPECT/CT systems, syngo.via MI Workplace may increase a facility’s clinical capabilities and can be expanded to accommodate an ever-evolving exam mix.
Mobile Biograph Horizon PET/CT
Siemens Healthineers also debuts the mobile configuration of its recently introduced Biograph Horizon PET/CT system, which delivers high-end functionality at an attractive total cost of ownership. This new mobile-ready version of Biograph Horizon is intended for cost-conscious health care facilities that do not yet possess the patient volume to support installation of a fixed PET/CT. The mobile configuration also may be ideal for consolidated health systems looking to tailor their imaging delivery strategy in diverse service areas.
Migrating technology from the company’s premium Biograph family of PET/CT systems to help providers address more clinical indications in oncology, neurology, and cardiology while also introducing new efficiencies and cost savings, Biograph Horizon enables physicians to visualize small lesions early. The system’s 4 mm LSO crystals scintillate faster and boast a higher light output than commonly used BGO crystals,2 yielding high image resolution and better image quality as well as enabling Time-of-Flight acquisition.3 By receiving more detailed patient data earlier, clinicians may stage disease and evaluate therapy response more accurately, contributing to more effective care pathways.
With the addition of the mobile version of Biograph Horizon, the entire line of Biograph PET/CT systems from Siemens Healthineers – including Biograph mCT and Biograph mCT Flow™1 – is available in mobile as well as fixed configurations.
Contact for journalists
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world’s largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of gas and steam turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2015, which ended on September 30, 2015, Siemens generated revenue of €75.6 billion and net income of €7.4 billion. At the end of September 2015, the company had around 348,000 employees worldwide. Further information is available on the Internet at www.siemens.com
1Biograph Horizon and Biograph mCT Flow are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
2Pepin, C.M., Bérard, P., Perrot, A., et al (2004). Properties of LYSO and Recent LSO Scintillators for Phoswich PET Detectors. IEEE Transactions on Nuclear Science, 51, 3.